Markus Joerger

Also affiliated with Kantonsspital St. Gallen, OST - Ostschweizer Fachhochschule, Swiss Group For Clinical Cancer Research, Ostschweizer Kinderspital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: “Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis”.

Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis

CPT: Pharmacometrics & Systems Pharmacology(2019)10.1002/psp4.12474

N/A

0.533DataRank · unranked

34 citations

Maarten J. Deenen, Markus Joerger, Hilde Rosing, Niels de Vries, Didier Meulendijks +5 more

Adjuvant Aspirin Treatment in PIK3CA -Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4048

N/A

0.434DataRank · unranked

17 citations

Stefanie Hayoz, Daniel Horber, Wolfram Jochum, Sara De Dosso, Dieter Koeberle +12 more

Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1500

N/A

0.312DataRank · unranked

7 citations

David S.P. Tan, Anastasios Stathis, Geoffrey I. Shapiro, Satoru Iwasa, Markus Joerger +17 more

Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial

Experimental Hematology & Oncology(2025)10.1186/s40164-025-00703-x

N/A

0.165DataRank · unranked

2 citations

Rémi Vernet, Muriel Urwyler, Olivier Von Rohr, Emily Charrier, Marie-Claude Belkouch +17 more

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations

European Journal of Cancer(2024)10.1016/j.ejca.2024.114024

N/A

0DataRank · unranked

26 citations

Markus Joerger, Yung‐Jue Bang, Ron H.J. Mathijssen, Caicun Zhou, Li Zhang +6 more

HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

British Journal of Cancer(2024)10.1038/s41416-024-02774-9

N/A

0DataRank · unranked

6 citations

Lenka Sedlaříková, L Buechler, Marianne Kraus, Chieh-Hsiang Yang, Nicol Straková +8 more